Cargando…

The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study

BACKGROUND: Obesity and its complications are associated with several adverse effects that may cause a serious impact on health. Antipsychotics-induced weight gain (AIWG) is one of the major, yet often neglected side effects of first and second generations antipsychotics. Importantly, several resear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hakami, Alqassem Y., Felemban, Razaz, Ahmad, Rami Ghazi, Al-Samadani, Abdulrahman H., Salamatullah, Hassan K., Baljoon, Jamil M., Alghamdi, Loay J., Ramadani Sindi, Mostafa H., Ahmed, Mohamed Eldigire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170991/ https://www.ncbi.nlm.nih.gov/pubmed/35686187 http://dx.doi.org/10.3389/fpsyt.2022.914165

Ejemplares similares

The Prevalence of Atypical Antipsychotics, Antidepressants, and Benzodiazepines Use in Dementia Patients in King Abdulaziz Medical City
por: Basaeed, Amani J, et al.
Publicado: (2022)

The effect of different types of anemia on HbA1c levels in non-diabetics
por: Alzahrani, Basil A., et al.
Publicado: (2023)

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
por: Prasad, Femin, et al.
Publicado: (2023)

Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial
por: Wang, Congjie, et al.
Publicado: (2020)

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

Prevalence of Selective Serotonin Reuptake Inhibitor Use Among Pregnant Women From 2017 to 2020 in King Abdulaziz Medical City, Jeddah, Saudi Arabia: A Retrospective Study
por: Hakami, Alqassem Y, et al.
Publicado: (2023)

Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
por: de Silva, Varuni Asanka, et al.
Publicado: (2016)

S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)

Melatonin attenuates morphine‐induced conditioned place preference in Wistar rats
por: Alshehri, Fahad S., et al.
Publicado: (2021)

Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
por: de Boer, Nini, et al.
Publicado: (2021)

Antibacterial Resistance Patterns Among Common Infections in a Tertiary Care Hospital in Saudi Arabia
por: Hakami, Alqassem Y, et al.
Publicado: (2022)

Prevalence of Behavioral Addictions and Their Relationship With Stress and Anxiety Among Medical Students in Saudi Arabia: A Cross-Sectional Study
por: Hakami, Alqassem Y., et al.
Publicado: (2021)

Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2018)

Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology
por: Fitzgerald, Ita, et al.
Publicado: (2022)

Analysis of Concomitant Medications Prescribed with Antipsychotics to Patients with Dementia
por: Saito, Yoshitaka, et al.
Publicado: (2023)

Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia
por: Kakunje, Anil, et al.
Publicado: (2018)

Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
por: Bak, Maarten, et al.
Publicado: (2021)

Effect of Seasonal Variation on Relapse Rate in Patients With Relapsing-Remitting Multiple Sclerosis in Saudi Arabia
por: Makkawi, Seraj, et al.
Publicado: (2022)

Effects of Amoxicillin and Augmentin on Cystine-Glutamate Exchanger and Glutamate Transporter 1 Isoforms as well as Ethanol Intake in Alcohol-Preferring Rats
por: Hakami, Alqassem Y., et al.
Publicado: (2016)

Altered gene expression in antipsychotic-induced weight gain
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2019)

Combination approaches to reduce weight-gain induced by antipsychotics
por: Hofer, A.
Publicado: (2021)

Metformin for Antipsychotic-Related Metabolic Syndrome in Children: Fact or Fiction?
por: Naguy, Ahmed, et al.
Publicado: (2018)

The lasting impact of COVID-19 on surgical training from the perspective of surgical residents and consultants in Saudi Arabia: a nationwide cross-sectional study
por: Qedair, Jumanah T., et al.
Publicado: (2023)

Primary renal cell carcinoma in crossed fused ectopia: Nephron sparing surgery for a rare of rarity entity
por: Tayeb, Waseem, et al.
Publicado: (2019)

Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics
por: Ramadas, Smitha, et al.
Publicado: (2022)

Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents
por: Goltz, Jeffrey Samuel, et al.
Publicado: (2017)

The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials
por: Mansuri, Zeeshan, et al.
Publicado: (2022)

Prevalence of Etiological Factors in Adult Patients With Epilepsy in a Tertiary Care Hospital in the Western Region of Saudi Arabia: A Cross-Sectional Study
por: Makkawi, Seraj, et al.
Publicado: (2023)

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
por: Morgan, Andrew P., et al.
Publicado: (2014)

Risk factors and pattern of weight gain in youths using antipsychotic drugs
por: van der Esch, Casper C. L., et al.
Publicado: (2020)

Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain
por: Murphy, Andrea Lynn, et al.
Publicado: (2013)

The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
por: Bretler, Tali, et al.
Publicado: (2019)

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
por: Libowitz, Mark R., et al.
Publicado: (2021)

The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
por: Battini, Vera, et al.
Publicado: (2023)

Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
por: Wu, R-R, et al.
Publicado: (2016)

The relationship between physical activity and burnout among respiratory therapists in Jeddah City, Saudi Arabia
por: Ahmad, Rami Ghazi, et al.
Publicado: (2022)

Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study
por: Tang, Charmaine, et al.
Publicado: (2021)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Metformin as a tool to control antipsychotic-induced metabolic syndrome - case report
por: Horosan, L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1vsgi9p83i6a6dtce309362s85